White Paper
Clinical Decision-Making in the Era of Generative AI
Emerging behavioral signals from European healthcare professionals
Apr 21, 2026

Clinical decision-making is entering a new phase as generative artificial intelligence becomes embedded in everyday medical practice. Across Europe, healthcare professionals are already using Gen AI tools to interpret evidence, validate clinical understanding, and explore treatment options - often outside formal institutional frameworks.

This white paper draws on an IQVIA multi-country survey of physicians in Germany, France, and the United Kingdom to examine how generative AI is being adopted in real-world clinical workflows. It explores emerging behavioral signals, usage patterns, trust dynamics, and governance gaps, and discusses the implications for medical affairs, commercial strategy, and engagement models in a GenAI-enabled healthcare environment.

In this white paper, you’ll learn:

  • How widely generative AI is already used by European healthcare professionals
  • What clinicians are using GenAI for in real clinical contexts
  • Where trust, transparency, and governance remain limiting factors
  • What emerging behavioral signals mean for medical, commercial, and engagement strategies

Related solutions

Contact Us